My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene.

    Wishart TM, Macdonald SH, Chen PE, Shipston MJ, Coleman MP, Gillingwater TH, Ribchester RR.

    Mol Neurodegener. 2007 Oct 30;2:21.PMID: 17971231 [PubMed - in process]Related articlesFree article

    2.

    The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy.

    Wang MS, Fang G, Culver DG, Davis AA, Rich MM, Glass JD.

    Ann Neurol. 2001 Dec;50(6):773-9.PMID: 11761475 [PubMed - indexed for MEDLINE]Related articles

    3.

    Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).

    Wishart TM, Pemberton HN, James SR, McCabe CJ, Gillingwater TH.

    Genome Biol. 2008;9(6):R101. Epub 2008 Jun 20.PMID: 18570652 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse.

    Coleman MP, Conforti L, Buckmaster EA, Tarlton A, Ewing RM, Brown MC, Lyon MF, Perry VH.

    Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9985-90.PMID: 9707587 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.

    Wishart TM, Paterson JM, Short DM, Meredith S, Robertson KA, Sutherland C, Cousin MA, Dutia MB, Gillingwater TH.

    Mol Cell Proteomics. 2007 Aug;6(8):1318-30. Epub 2007 Apr 29.PMID: 17470424 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    WldS mice are resistant to paclitaxel (taxol) neuropathy.

    Wang MS, Davis AA, Culver DG, Glass JD.

    Ann Neurol. 2002 Oct;52(4):442-7.PMID: 12325073 [PubMed - indexed for MEDLINE]Related articles

    7.

    Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.

    Wishart TM, Brownstein DG, Thomson D, Tabakova AM, Boothe KM, Tsao JW, Gillingwater TH.

    BMC Neurosci. 2009 Dec 16;10:148.PMID: 20015399 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Rapid genotyping of mutant mice using dried blood spots for polymerase chain reaction (PCR) analysis.

    Campbell DB, Hess EJ.

    Brain Res Brain Res Protoc. 1997 May;1(2):117-23.PMID: 9385073 [PubMed - indexed for MEDLINE]Related articles

    9.

    The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.

    Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP.

    BMC Neurosci. 2005 Feb 1;6:6.PMID: 15686598 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Genotyping methods to detect a unique neuroprotective factor (Wld(s)) for axons.

    Mi W, Conforti L, Coleman MP.

    J Neurosci Methods. 2002 Jan 30;113(2):215-8.PMID: 11772443 [PubMed - indexed for MEDLINE]Related articles

    12.

    Stable inheritance of an 85-kb triplication in C57BL/WldS mice.

    Mi W, Glass JD, Coleman MP.

    Mutat Res. 2003 May 15;526(1-2):33-7.PMID: 12714180 [PubMed - indexed for MEDLINE]Related articles

    13.

    Elimination of motor nerve terminals in neonatal mice expressing a gene for slow wallerian degeneration (C57Bl/Wlds).

    Parson SH, Mackintosh CL, Ribchester RR.

    Eur J Neurosci. 1997 Aug;9(8):1586-92.PMID: 9283813 [PubMed - indexed for MEDLINE]Related articles

    15.

    Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.

    Watanabe M, Tsukiyama T, Hatakeyama S.

    Neurosci Lett. 2007 Jan 16;411(3):228-32. Epub 2006 Nov 17.PMID: 17113230 [PubMed - indexed for MEDLINE]Related articles

    16.

    Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion.

    Gillingwater TH, Ingham CA, Parry KE, Wright AK, Haley JE, Wishart TM, Arbuthnott GW, Ribchester RR.

    Brain. 2006 Jun;129(Pt 6):1546-56.PMID: 16738060 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    NAD and axon degeneration: From the Wlds gene to neurochemistry.

    Wang J, He Z.

    Cell Adh Migr. 2009 Jan 25;3(1). [Epub ahead of print]PMID: 19372760 [PubMed - as supplied by publisher]Related articles

    18.

    WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.

    Beirowski B, Morreale G, Conforti L, Mazzola F, Di Stefano M, Wilbrey A, Babetto E, Janeckova L, Magni G, Coleman MP.

    Neuroscience. 2010 Mar 10;166(1):201-11. Epub 2009 Dec 16.PMID: 20018231 [PubMed - in process]Related articles

    19.

    The novel PCR-based technique of genotyping applied to identification of scrambler mutation in mice.

    Usman N, Tarabykin V, Gruss P.

    Brain Res Brain Res Protoc. 2000 Jul;5(3):243-7.PMID: 10906489 [PubMed - indexed for MEDLINE]Related articles

    20.

    The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice.

    Gillingwater TH, Ribchester RR.

    J Neurocytol. 2003 Jun-Sep;32(5-8):863-81. Review.PMID: 15034273 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk